The Latest Breaking News from HIV

AmfAR, set up by Elizabeth Taylor, is known for hosting lavish parties and raising huge sums for HIV and Aids research

The U.K.’s National Institute for Health and Care Excellence (NICE) is recommending a treatment from a firm jointly owned by GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE) and Shionogi Inc.

The drug, known as cabotegravir, must be administered every two months.

Long-acting injection offers alternative to daily pills taken to protect against the virus

The National Institute for Health and Care Excellence recommended the injection for people at risk of HIV who are unable to take oral PrEP.

The rollout is expected to begin around three months after Nice publishes its final guidance later this year

South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs until the end of March

The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in 2023. This is despite growing availability of a highly effective HIV prevention medication that has made it possible to live a long, healthy life with this once fatal…

For the 2.3 million residents of Lesotho, the announcement of massive cuts to the U.S. aid that sustained much of the small African nation’s health care system came as a shock. The country long had one of the world’s highest HIV infection rates but recently made notable progress and hit…

In the wake of massive U.S. cuts to foreign aid, the tiny country of Lesotho in southern Africa faces deep uncertainty and worry over its HIV-positive residents

With the single stroke of Trump’s pen, much of a system credited with saving hundreds of thousands of lives was dismantled